FDA Inspection
Unilever Manufacturing (US), Inc.Unilever Manufacturing (US), Inc. – FDA Inspection, Sep 15, 2025
Record Details
This FDA Inspection record concerns Unilever Manufacturing (US), Inc., with an inspection on September 15, 2025, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 3d172843-ae58-4695-8959-02871d2bad7a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1282240
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.194(a)(2)Reference and method not stated
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.194(a)(2)Suitability of testing methods verified
- 21 CFR 211.166(a)(2)Stability sample storage conditions described
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Unilever Manufacturing (US), Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Unilever Manufacturing (US), Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.